HCV - Millenia Hope Acquires AIDS Patent

Millenia Hope Acquires AIDS Patent
[Press Release] PR Newswire via Yahoo! Finance - Feb 28 5:34 AM
Millenia Hope Inc., a biopharma corporation , has acquired a patent on AIDS that specifically describes compounds that inhibit HIV-1 RNase_H.Save to My Web

Clinical Trial Results Show that Peregrine's First-In-Class Anti-Viral Agent Tarvacin(TM) is Safe and Well-Tolerated in
[Press Release] PR Newswire via Yahoo! Finance - Feb 27 4:00 AM
Peregrine Pharmaceuticals, Inc. , a biopharmaceutical company with a portfolio of innovative, clinical stage product candidates for viral diseases and cancer, today announced that it will present top line data demonstrating that its first-in-class anti-viral compound Tarvacin Anti-Viral appeared safe and well-tolerated in a Phase l study in chronic hepatitis C virus infected patients.Save to My Web

Clinical Trial Results Show That Peregrine's First-In-Class Anti-Viral Agent Tarvacin(TM) Is Safe And Well-Tolerated In
Medical News Today - Feb 27 4:06 PM
Peregrine Pharmaceuticals, Inc. (PPHM), a biopharmaceutical company with a portfolio of innovative, clinical stage product candidates for viral diseases and cancer, today announced that it will present top line data demonstrating that its first-in-class anti-viral compound Tarvacin(TM) Anti-Viral appeared safe and well-tolerated in a Phase l study in chronic hepatitis C virus (HCV) infected Save to My Web

Experts warn public on dangers of Hep C
Australian Broadcasting Corporation - Feb 18 12:12 AM
ELIZABETH JACKSON: Health experts are warning that Australia doesn't have the resources to deal with a burgeoning epidemic of viral hepatitis, a debilitating disease, which affects the liver.Save to My Web